Pharmathen SA

We develop complex drug delivery and formulations to enhance patient compliance and offer affordable, high-quality medicines globally. We serve 250+ customers across 90+ countries globally including Europe, North America, South America, Middle East & North Africa, Asia-Pacific. Our portfolio includes over 100 products: Finished Dosages (including long-acting injectables, peptides, modified-release orals, other complex ophthalmics and injectables); & APIs (peptides and others). All products are manufactured in FDA and EU-approved GMP facilities.